MAPT and progressive supranuclear palsy: The purpose of this study was to evaluate OLX-07010, a small molecule inhibitor of tau self-association, for the prevention of tau aggregation in JNPL3 mice, representative of inherited forms of 4-repeat tauopathies with the P301L tau mutation, such as progressive supranuclear palsy and frontotemporal dementia.